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1. Introduction 
Human immunoglobulin D (IgD) is present in low 
concentrations in normal human serum, usually less 
than 1% of the total immunoglobulin population [l] . 
Little is known of the physiological role of this 
immunoglobulin class since IgD molecules appear to 
lack the structural requirements for many effector 
functions, such as skin sensitisation and complement 
activation [2]. There have also been few reports of 
antibody activity associated with IgD. However, 
recent work suggests that IgD may be particularly 
active as a lymphocyte membrane antigen receptor 
[3]. Chemically-derived data, such as the lack of 
convincing homology of the ‘hinge’ region with other 
human immunoglobulin heavy chain sequences [4], 
the comparatively low proline content [5] , the 
distinctive susceptibility to proteolysis and high 
carbohydrate content [6], all suggest a unique 
structure of IgD within the general immunoglobulin 
structural pattern of two heavy and two light poly- 
peptide chains. 
We have studied two isolated IgD myeloma proteins 
using circular dichroism (CD) and isoelectric focusing 
(IEF) in order to try to clarify any unusual structural 
features of the molecule that could be responsible for 
the distinctive physiological behaviour of this immuno- 
globulin class. Neither the IEF pattern nor the CD 
spectra of IgD have been reported previously. 
2. Materials and methods 
Serum from tyo patients (A and B) suffering from 
multiple myeloma (IiD) were generous gifts from 
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Dr I. C. M. MacLennan and Dr 0. Cromwell, 
respectively. Following precipitation with 19.3% 
ammonium sulphate containing 4% NaCl ,30 mg of 
each immunoglobulin fraction were electrofocused on 
a preparative LKB Uniphor sucrose gradient at 4°C 
as previously described [7]. Fractions containing IgD 
eluted between pl 5.4 to 6.1 for IgD ‘A’ and 4.7 to 
5.8 for IgD ‘B’. These fractions were pooled and 
concentrated by ultrafiltration. 
Analysis of the purified proteins by immuno- 
electrophoresis howed no reaction against antisera 
specific for human y, (Y or p heavy chains and a single 
precipitin line against rabbit antiserum specific for 
6 heavy chains (fig. 1). The rabbit antiserum to human 
6 heavy chain was a kind gift from the Department of 
Experimental Pathology, Birmingham University. A 
single precipitin line against antisera specific for L- 
type light chains was also obtained with both IgD 
preparations. 
Analytical isoelectric focusing of the purified IgD 
myeloma proteins in 7.5% polyacrylamide rods was 
carried out as described previously [8]. Ampholine 
carrier ampholytes (PH 4-9) were used. 
Circular dichrojc spectra were recorded on a Cary 
61 recording spectropolarimeter as described 
previously [9]. AU samples had been dialysed against 
O.OlM Na2HP04-NaH2P04 buffer, pH 7.4, and passed 
through a sterile Millipore filter (0.45 p) immediately 
prior to CD analysis. A mean residue weight of 109 
was assumed and data are expressed as mean residue 
ellipticity (0’)in degrees. cm’/decimole. Protein 
concentrations were determined spectrophoto- 
metrically using an extinction coefficient as 280 nm 
ofE ;;, = 14.5 for IgD [6]. 
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Fig. 1. Immunoelectrophoresis of IgD ‘A’ (bottom well) and IgD ‘B’ (top well) against rabbit antiserum to human 6 chains. Anode 
on right. 
3. Results and discussions 
Both IgD myeloma proteins showed a high degree of 
microheterogeneity when analysed by isoelectric 
focusing (fig. 2). They focused between p1 values of 
5.4-6.1 for IgD ‘A’ and 4.7-5.8 for IgD ‘B’. Both 
proteins exhibited similar multi-line patterns of greater 
than 10 lines. Williamson et al. [lo] have proposed 
that the microheterogeneity of IgG myeloma proteins 
on IEF is due to deamidation of the polypeptide 
chains. However the IgD myeloma proteins exhibit a 
higher degree of heterogeneity than IgG myeloma 
proteins [ 111 and their IEF pattern is similar to that 
shown by IgA myeloma proteins, for which the 
microheterogeneity has been ascribed to the carbohy- 
drate content and the acidity of the isoelectric points 
Fig. 2. Electrofocusing pattern for IgD ‘A’ (top tube) and IgD ‘B’ (bottom tube). pH range 4-9, anode on left. 
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Fig. 3. Circular dichroism spectra of IgD ‘A’, (-----); and IgD ‘B’ ( ----_) The ellipticity scale is expanded in the right hand 
figure to show greater spectral detail between 250 nm and 320 nm. 
to the high siahc acid content [ 121. Indeed, the nature 
of the digosaccharide content has been shown to be 
analogous for human IgA and IgD [ 131. 
The CD spectrum of both IgD myeloma proteins is 
shown in fig. 3. The large negative transition at 217 nm 
is a common feature of other human immunoglobulin 
classes and has been implicated as characteristic of the 
p-structure of the polypeptide bonding [ 141. The size 
of this transition and that of the positive transition at 
200 nm indicate that the secondary structure of both 
these human IgD myeloma proteins is very similar in 
nature and magnitude to that found in the other 
human immunoglobulin classes. At higher wavelengths, 
the smaller transitions are characteristic of the 
asymetric environment of the aromatic and disulphide 
groupings. Both IgD myeloma proteins exhibited a 
similar series of positive transitions between 250 and 
3 10 nm. Such a CD spectrum in this wavelength 
region is also similar to that reported for rabbit IgG 
[ 151 and human IgE [I 61; both human IgG [9] and 
human IgM (unpublished observations) show predomi- 
nantly negative transitions in this wavelength region. 
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The two IgD proteins differed in their CD spectra 
by the presence of a strong positive absorption at 
232 nm in the spectrum of IgD ‘B’. A transition at 
this wavelength and of the same order ofmagnitude 
has been observed previously for IgG 3 subclass 
proteins [9]. The origin of this transition has been 
discussed [9] and, by analogy to IgG myeloma 
proteins, a subclass difference between these two IgD 
myeloma proteins can be inferred. However, we could 
not obtain supporting evidence by the detection of 
any ‘spurring’ of precipitin lines on double radial 
immunodiffusion analysis against antiserum mono- 
specific for S heavy chains. 
We conclude from the CD analysis of two human 
IgD myeloma proteins that there are no exceptional 
features characteristic of either secondary or tertiary 
structure that may account for the unusual biophysical 
properties of this immunoglobulin class. Hence, the 
lack of many effector functions could result from 
differences in primary amino-sequence. However 
Kehoe et al. [17] have recently suggested that the 
complement-binding site is dependent on the con- 
Volume 49, number 3 FEBS LETTERS January 1975 
formation of at least part of the C,2 domain. Our 
IEF results suggest hat the binding of carbohydrate 
moieties to IgD may be crucial to its physiological 
role since they appear to bestow IgD myeloma proteins 
with a low p1 value and high degree of microhetero- 
geniety. 
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